A third US company has released research data showing its coronavirus vaccine is safe and elicits an immune response.<br />According to CNN, Novavax, Inc. released Phase 1 results on Tuesday.<br />The data shows that after two doses of the vaccine, participants developed neutralizing antibodies.<br />The antibodies developed were four times higher than those developed by people who had recovered from Covid-19.<br />The vaccine also induced a response from T-cells, a type of immune cell.<br />Novavax, Moderna, Pfizer, Johnson & Johnson, AstraZeneca and GlaxoSmithKline are all working on a vaccine.
